Pinazepam

DB13335

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 308.762
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

712 Data
Buprenorphine Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Hydrocodone Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Magnesium sulfate The therapeutic efficacy of Pinazepam can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Pinazepam may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Mirtazapine Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Orphenadrine Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Pramipexole Pinazepam may increase the sedative activities of Pramipexole.
Ropinirole Pinazepam may increase the sedative activities of Ropinirole.
Rotigotine Pinazepam may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Pinazepam.
Suvorexant Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Thalidomide Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Clozapine The risk or severity of adverse effects can be increased when Pinazepam is combined with Clozapine.
Methadone Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Olanzapine The risk or severity of CNS depression can be increased when Olanzapine is combined with Pinazepam.
Phenytoin The serum concentration of Phenytoin can be increased when it is combined with Pinazepam.
Fosphenytoin The serum concentration of Fosphenytoin can be increased when it is combined with Pinazepam.
Sodium oxybate Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Teduglutide The serum concentration of Pinazepam can be increased when it is combined with Teduglutide.
Yohimbine The therapeutic efficacy of Pinazepam can be increased when used in combination with Yohimbine.
Ethanol Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Zimelidine The risk or severity of adverse effects can be increased when Pinazepam is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Pinazepam is combined with Dapoxetine.
Seproxetine The risk or severity of adverse effects can be increased when Pinazepam is combined with Seproxetine.
Fluvoxamine The risk or severity of adverse effects can be increased when Pinazepam is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Pinazepam is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Pinazepam is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Pinazepam is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Pinazepam is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Pinazepam is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Pinazepam is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Pinazepam is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Pinazepam is combined with Escitalopram.
Milnacipran The risk or severity of adverse effects can be increased when Pinazepam is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Pinazepam is combined with Desvenlafaxine.
Levomilnacipran The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Pinazepam.
Indalpine The risk or severity of adverse effects can be increased when Pinazepam is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Pinazepam is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Pinazepam is combined with Alaproclate.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Pinazepam.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Pinazepam.
Zopiclone The risk or severity of adverse effects can be increased when Pinazepam is combined with Zopiclone.
Caffeine The therapeutic efficacy of Pinazepam can be decreased when used in combination with Caffeine.
Theophylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Theophylline.
Dyphylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Dyphylline.
Pentoxifylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Pentoxifylline.
Mercaptopurine The therapeutic efficacy of Pinazepam can be decreased when used in combination with Mercaptopurine.
Aminophylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Aminophylline.
Oxtriphylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Oxtriphylline.
Theobromine The therapeutic efficacy of Pinazepam can be decreased when used in combination with Theobromine.
Fenethylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Fenethylline.
8-azaguanine The therapeutic efficacy of Pinazepam can be decreased when used in combination with 8-azaguanine.
7,9-Dimethylguanine The therapeutic efficacy of Pinazepam can be decreased when used in combination with 7,9-Dimethylguanine.
Xanthine The therapeutic efficacy of Pinazepam can be decreased when used in combination with Xanthine.
7-Deazaguanine The therapeutic efficacy of Pinazepam can be decreased when used in combination with 7-Deazaguanine.
Guanine The therapeutic efficacy of Pinazepam can be decreased when used in combination with Guanine.
9-Methylguanine The therapeutic efficacy of Pinazepam can be decreased when used in combination with 9-Methylguanine.
Peldesine The therapeutic efficacy of Pinazepam can be decreased when used in combination with Peldesine.
Hypoxanthine The therapeutic efficacy of Pinazepam can be decreased when used in combination with Hypoxanthine.
9-Deazaguanine The therapeutic efficacy of Pinazepam can be decreased when used in combination with 9-Deazaguanine.
Propentofylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Propentofylline.
Valomaciclovir The therapeutic efficacy of Pinazepam can be decreased when used in combination with Valomaciclovir.
3-isobutyl-1-methyl-7H-xanthine The therapeutic efficacy of Pinazepam can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine.
Uric acid The therapeutic efficacy of Pinazepam can be decreased when used in combination with Uric acid.
Doxofylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Doxofylline.
6-O-benzylguanine The therapeutic efficacy of Pinazepam can be decreased when used in combination with 6-O-benzylguanine.
Lisofylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Lisofylline.
Lobucavir The therapeutic efficacy of Pinazepam can be decreased when used in combination with Lobucavir.
Cafedrine The therapeutic efficacy of Pinazepam can be decreased when used in combination with Cafedrine.
Theodrenaline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Theodrenaline.
Bamifylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Bamifylline.
Proxyphylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Proxyphylline.
Acefylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Acefylline.
Etamiphylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Etamiphylline.
Pentifylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Pentifylline.
Bufylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Bufylline.
Bromotheophylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Bromotheophylline.
Furafylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with Furafylline.
8-chlorotheophylline The therapeutic efficacy of Pinazepam can be decreased when used in combination with 8-chlorotheophylline.
PCS-499 The therapeutic efficacy of Pinazepam can be decreased when used in combination with PCS-499.
Botulinum toxin type B The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Pinazepam.
Botulinum toxin type A The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Pinazepam.
Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pinazepam.
Ethchlorvynol The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Pinazepam.
Succinylcholine The risk or severity of CNS depression can be increased when Succinylcholine is combined with Pinazepam.
Eletriptan The risk or severity of CNS depression can be increased when Eletriptan is combined with Pinazepam.
Enflurane The risk or severity of CNS depression can be increased when Enflurane is combined with Pinazepam.

Target Protein

GABA(A) Receptor GABRA1
GABA(A) Receptor Benzodiazepine Binding Site GABRA1

Referensi & Sumber

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul